Cancer treatment during Covid-19
3 August, 2020
"Our key priority is to ensure cancer patients have access to diagnostics, chemotherapy and radiotherapy where they need it, which has an even greater importance during Covid-19." Read more from James McArthur, General Manager UK.
29 July, 2020
Cancer diagnosis and treatment shouldn’t be delayed. Read the highlights from #AskGenesisCare
During our Twitter takeover on 22nd July to #AskGenesisCare, James McArthur, General Manager – UK was responding to your comments and questions. Take a read at some of the highlights….
29 July, 2020
New Haematology Rapid Access Service launches at GenesisCare in Milton Keynes
We are pleased to announce the launch of our new Haematology Rapid Access Service at our centre in Milton Keynes. This easy-to-access service enables you to refer your patients quickly to a Consultant Haematologist for assessment, diagnosis and potential treatment, with same day or next day appointments.
28 July, 2020
The last year has seen several significant milestones for the GenesisCare SABR service. Dr James Good shares our developments and looking ahead to the coming year.
21 July, 2020
World-class care during Covid-19 – is this still achievable?
“Our patients are the true unsung heroes of this pandemic and together we should continue to fight in the face of adversity.” A compelling article by Louise Pardon, our talented SABR specialist radiographer, the GenesisCare teams continue to adopt and deliver cancer care safely for patients.
11 July, 2020
Do you have a question about continuing cancer care safely during Covid-19?
James McArthur, General Manager – UK will be doing an exclusive Twitter takeover on Wednesday 22nd July, 6-7:30pm and we invite you to #AskGenesisCare and join the conversation.
25 June, 2020
Diagnostic and advanced radiotherapy for prostate cancer
At GenesisCare, we provide a clear and comprehensive pathway from diagnosis to treatment for prostate cancer patients who wish to be referred privately. In the treatment of the most common cancer in men, recent advances in radiotherapy have also given us new opportunities to improve outcomes and quality of life for patients.
22 June, 2020
The technological benefits of prostate radiotherapy on the MRIdian
Prostate cancer is the most common cancer in men in the UK. Around 6 out of 10 men will have localised disease at presentation, and approximately a third of these will go on to have curative radiotherapy. Radiotherapy treatment for prostate cancer has changed beyond recognition over the last 20 years, due to advances in…
17 June, 2020
Dave’s 155 mile cycle for Penny Brohn UK
Dave’s sheer determination to complete the challenge for Penny Brohn UK and to cover his longest distance in a single day did not stop. From indoor training during strict lockdown measures to beginning to cycle further distances when the restrictions were lifted – Dave did not stop peddling! And within government guidelines Dave decided to…
16 June, 2020
Stereotactic Ablative Radiotherapy (SABR) – an alternative to surgery
SABR is an effective alternative to surgery in cancers such as prostate, pancreatic, renal and lung. In addition, the use of SABR can help patients to safely delay chemotherapy or provide tumour control instead of chemotherapy.
